Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer

Clinical trial NCT00455572 · TERMINATED

Trial details

NCT number: NCT00455572
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Cancer, Non-Small Cell

Start date: 2007-05-11
Primary completion: 2013-08-04
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.